BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
DNMT1
,
cell-cell adhesion
,
Leukemia
,
Adipose tissue
,
Avian flu virus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
antigens Env
Summary
General Info
Curated Studies
Most Correlated Studies
Acute monocytic leukemia (AML) THP-1 cells HIV gp120 or LPS stimulated following SB203580 treatment
B cells activated with anti-IgM and CpG DNA then treated with high affinity HIV gp120 protein R66M
Neuronal damage by HIV glycoprotein 120 expression in CCR5 KO and wildtype mice
Dorsal root ganglia from rats modeling neuropathic pain by treatment with gp120 with ddC
PBMCs of donors immunized with RV144 (ALVAC-gp120) HIV vaccine showing high or low ADCP
Explore Curated Studies Results
Literature
Most Relevant Literature
Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, …
Expression profiles of human endogenous retrovirus (HERV)-K and HERV-R Env proteins in various cance…
Analysis of KAP1 expression patterns and human endogenous retrovirus Env proteins in ovarian cancer.
Super-Resolution STED Microscopy-Based Mobility Studies of the Viral Env Protein at HIV-1 Assembly S…
HIV-1 Lethality and Loss of Env Protein Expression Induced by Single Synonymous Substitutions in the…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59
A Study to Assess the Safety and Immune Response to Env-C DNA and Protein Vaccines in Kenya
Evaluating the Safety and Immunogenicity of the IHV01 Protein Vaccine Primed and Co-Administered Wit…
A Trial to Evaluate Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers
A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted E…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ